ClinicalTrials.gov
ClinicalTrials.gov Menu

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00511303
Recruitment Status : Completed
First Posted : August 3, 2007
Last Update Posted : August 3, 2007
Sponsor:
Collaborator:
Novartis
Information provided by:
University of Bologna

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given